Areteia Therapeutics
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
$75M Series A ·
Led by Bain Capital Life Sciences · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredApr 8, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $75M | fundraisingfox.com |
Timeline
- Website created
Founders and team
CC
Christopher Courts FounderJB
Jorge Bartolome FounderWB
Whit Bernard FounderCP
Calman Prussin Senior Vice President, Chief Scientific OfficerEB
Eric Bradford Chief Medical OfficerMK
Mark Kreston SVP & Chief Commercial OfficerPW
Peter Wijngaard Chief Development OfficerRW
Robin Walker Chief Legal Officer and Corporate Secretary
Investors
AAccess Biotechnology
AARCH Venture Partners
BBain Capital Life Scienceslead investor
GGV
MMarshall Wace
MMaverick Capital
PPopulation Health Partners
SSanofi
SSaturn Partners
VViking Global Investors
Companies like Areteia Therapeutics
KKinaset Therapeutics$103M Series B+ · Jan 2026
CCity TherapeuticsSeries B+ · Aug 2026
PPathalysSeries B+ · Aug 2024
NNavion Neurosciences$10.8M Seed · Sep 2026
VVaderis Therapeutics$152M Series B+ · Aug 2026
CCirrus Therapeutics$14.7M Seed · Aug 2026
Other companies backed by Bain Capital Life Sciences
OOMass Therapeutics$310M Series B+ · Oct 2026
AAdvanCell$315M Series B+ · Jul 2026
AAngitia Bio$130M Series B+ · Feb 2026
SSyremis Therapeutics$165M Series A · Dec 2025
MMerida Biosciences$120M Series A · May 2025
CCardurion Pharmaceuticals$260M Series B+ · Jul 2024
Bain Capital Life Sciences portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/areteia-therapeutics (get a free API key).